Monash University ranks #2 in the world for Pharmacy and Pharmacology

Monash University Parkville Campus

Monash has retained its position as one of the top universities in the world for Pharmacy and Pharmacology in the 2023 QS World University Rankings by Subject, with a global ranking of number two.

The University has retained its long-held position as Australia and the Asia-Pacific’s number one University for Pharmacy and Pharmacology and has consistently ranked in the most elite group of Pharmacy and Pharmacology programs worldwide, with an average top three ranking for the last five years.

Professor Arthur Christopoulos FAA FAHMS, Dean of Monash’s Faculty of Pharmacy and Pharmaceutical Sciences, said that the University’s consistently high ranking in this subject area is attributed to Monash’s continuous drive to be at the forefront of research, practice and education on the world stage.

“Pharmacists and pharmaceutical scientists are the experts in medicines and the way they interact with the body. Together with our medical and allied health care practitioners, they play a vital role in our healthcare system. As the world collectively tackles a number of global health challenges, our Faculty has continued to evolve our education and research programs in response to urgent global workforce demands, and to address a broad range of unmet medical needs.”

The Faculty, world-renowned for its high profile research through the Monash Institute of Pharmaceutical Sciences (MIPS), chalked up yet another series of major successes over the last year, including establishing the Neuromedicines Discovery Centre, an end-to-end academic enterprise for the discovery, development, evaluation, manufacture, and clinical rollout of 21st-century medicines to treat mental health disorders, as well as the Victorian mRNA Innovation Hub, a collaborative initiative to develop next-generation mRNA vaccines and therapeutics to treat a range of diseases.

“In the last year we’ve also continued to play a key role in the launch of new biotech startups including Septerna, which launched with $140 million (AUD) worth of Series A financing from tier-one venture capital firm Third Rock Ventures in the US, making it the largest startup to ever come out of Monash University, along with Phrenix Therapeutics to advance research to develop new therapeutics for cognitive disorders, particularly in schizophrenia, and Ankere Therapeutics which is dedicated to the development of new therapies that target inflammatory diseases, particularly those affecting the lung,” said Professor Christopoulos.

The Faculty has also led the way in the COVID-19 and influenza vaccine rollout, with pharmacy educators helping to train Victoria’s first ever cohort of pharmacy students to administer vaccines as part of a government-driven effort to bolster the state’s immunisation program.

In addition to being at the forefront of education and research, the Faculty is also home to Her Research Matters (HRM), a collective established in 2019 to promote and foster an inclusive and equitable leadership environment for women in academia. Together with the Faculty’s leadership team and our international leading Pharmacy School collaborators in the ‘PharmAlliance’, HRM has been a driving force behind increasing the proportion of women Associate Professors and Professors from 23 per cent in 2019, to 36 per cent in 2023.

On the education front, recent notable achievements include MyDispense - a virtual dispensing platform designed by the Faculty - being named a winner in The Australian Financial Review Higher Education Awards, and several pharmacy educators recently winning awards in the 2022 Australian Awards for University Teaching.

The QS World University Rankings assess the performance of almost 1,500 universities worldwide. The Rankings are compiled from an analysis of more than 16.4 million unique papers, 117.8 million citations and global surveys by employers and academics.

For more information about the rankings visit

Read more about Monash University’s overall rankings here.